Corneal endothelial deposits associated with rifabutin use

Journal of Ocular Pharmacology and Therapeutics

Volumn 21, Issue 2, 2005, Pages 166-169

  Coutinho, Anamaria Baptista ^a,b,c,d   Cheema, Devinder ^c   Pereira, Patricia R ^a,b   Souza Filho, João P ^a,b   Burnier Jr , Miguel N ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d Lyman Duff Building ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ATAZANAVIR; CLARITHROMYCIN; COTRIMOXAZOLE; DIDANOSINE; ENFUVIRTIDE; ETHAMBUTOL; FENOFIBRATE; INDINAVIR; LAMIVUDINE; RIFABUTIN; RITONAVIR; TENOFOVIR; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CORNEA DISEASE; CORNEA ENDOTHELIUM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PIGMENTATION; SCHOOL CHILD; SLIT LAMP; TUBERCULOSIS; VISUAL ACUITY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; CHILD; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM, CORNEAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; RETROSPECTIVE STUDIES; RIFABUTIN; TUBERCULOSIS, LYMPH NODE;

EID: 17744369267     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2005.21.166     Document Type: Article

References (12)

1. Arevalo, J.F., Russack, V., and Freeman, W.R. New ophthalmic manifestations of presumed rifabutin-related uveitis. Ophthal. Surg. Lasers. 28:321-324, 1997.
2. Golchin, B., and McClellan, K. Corneal endothelial deposits secondary to rifabutin prophylaxis for Mycobacterium avium complex bacteraemia. Br. J. Ophthalmol. 87:798-799, 2003.
3. Skinner, M.H., and Blaschke, T.F. Clinical pharmacokinetics of rifabutin. Clin. Pharmacokinet. 28:115-125, 1995.
4. Ponjavic, V., Granse, L., Stigmar, E.B., et al. Retinal dysfunction and anterior segment deposits in a patient treated with rifabutin. Acta. Ophthalmol. Scand. 80:553-556, 2002.
5. Chu, D.S., Zaidman, G.W., Meisler, D.M., et al. Human immunodeficiency virus-positive patients with posterior intracorneal precipitates. Ophthalmology 108: 1853-1857, 2001.
6. Jacobs, D.S., Piliero, P.J., Kuperwaser, M.G., et al. Acute uveitis associated with rifabutin use in patients with human immunodeficiency virus infection. Am. J. Ophthalmol. 118:716-722, 1994.
7. Saran, B.R., Maguire, A.M., Nichols, C., et al. Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch. Ophthalmol. 112:1159-1165, 1994.
8. Karbassi, M., and Nikou, S. Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin. Arch. Ophthalmol. 113:699-701, 1995.
9. Fuller, J.D., Stanfield, L.E.D., and Craven, D.E. Rifabutin prophylaxis and uveites. N. Engl. J. Med. 330:1315-1316, 1994.
10. Shafran, S.D., Deschenes, J., Miller, M., et al. Uveites and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. N. Engl. J. Med. 330:438-439, 1994.
11. Smith, J.A., Mueller, B.U., Nussenblatt, R.B., et al. Corneal endothelial deposits in children positive for human immunodeficiency viris receiving rifabutin prophylaxis for Mycobacterium avium complex bacteremia. Am. J. Ophthalmol. 127:164-169, 1999.
12. Holland, S.P., Chang, C.W., Vagh, M., et al. Corneal endothelial deposits in patients with HIV infection or AIDS: Epidemiologic evidence of the contribution of rifabutin. Can. J. Ophthalmol. 34:204-209, 1999.